Bringing the Oncology Community Together
Head & Neck
Janet Hampton on the Distress Thermometer Study Results
Janet Hampton, RN, BS
Tuesday, May 24, 2011
Janet Hampton, RN, BS, OCN® from the University of Michigan Health System Cancer Center Explains Distress Thermometer Study Results
SEE ALL VIDEOS FROM: Janet Hampton, RN, BS
Optimizing Treatment of Advanced Pancreatic Cancer
Panelist discuss research focused on the optimization of treatment approaches for patients with pancreatic cancer, with a focus on adjuvant therapies and localized disease.
Cost Effectiveness of Therapies in Pancreatic Cancer
E. Gabriela Chiorean, MD, discusses the cost-effectiveness of first-line combination therapies commonly used to treat patients with metastatic pancreatic cancer.
Gemcitabine/Nab-Paclitaxel in Advanced Pancreatic Cancer
In this segment, panelists discuss the recent approval of nab-paclitaxel plus gemcitabine and their selection of a first-line therapy for patients with advanced pancreatic cancer.
Dr. Fine on GTX in Inoperable Pancreatic Cancer
Dr. Bendell on using OMP-59R5 to treat Pancreatic Cancer
Dr. Ramanathan on an Analysis of the MPACT Trial
Most Popular Right Now
Onartuzumab Falters in Late-Stage NSCLC Trial
Peregrine’s Lead Agent Receives FDA Fast Track Designation for NSCLC
Study Supports First-Line Eribulin Therapy in Metastatic Breast Cancer
Success of First BTK Inhibitor Opens New Options in B-Cell Malignancies
Chemotherapy is Indicated, Yet Used Infrequently, in Patients With MIBC
Tweets by @OncLive
Ruxolitinib Improves Outcomes for Patients With Polycythemia Vera in Phase III Study
American Journal of Managed Care
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
666 Plainsboro Road
Plainsboro, NJ 08536
Copyright OncLive 2006-2013
Intellisphere, LLC. All Rights Reserved.